Research

October 28, 2024

New research highlights economic and employment challenges for parents of medically complex babies

The study highlights that having a preterm baby often forces parents to consider leaving their job, a decision that typically involves changes to health insurance plans and networks, and resets the annual out-of-pocket costs a worker incurs.

By Holly Fletcher
October 25, 2024

Blockbuster obesity drugs also may slow kidney disease

The report supports previous clinical trials that found the GLP-1 receptor agonist drug semaglutide reduced kidney disease progression in patients with Type 2 diabetes.

By Bill Snyder
October 25, 2024

Asthma drug does not speed COVID-19 recovery: study

The study, a randomized and controlled clinical trial, tested the effectiveness of montelukast in 1,250 outpatients with acute post-COVID-19 symptoms.

By Bill Snyder and Shantell Kirkendoll
October 22, 2024

VUMC, Nigeria teaching hospital to study genetic risk of fibroids based on regional African ancestry

The research team will analyze existing genome-wide association study data and RNA sequencing to compare fibroid development patterns in Nigerian women and U.S. Black women, which could point to targeted therapies and management strategies for affected women.

By Kristin Centers
October 21, 2024

Clue to salt-sensitive blood pressure found

Despite the well-established link between high salt intake and cardiovascular disease and stroke, the mechanism of SSBP is poorly understood, and it remains an untreatable cardiovascular risk with no widely available diagnostic tool.

By Bill Snyder
October 18, 2024

All of Us tour stops at VUMC Oct. 22-25

The All of Us Research Program brings the future of health to VUMC and Nashville. 
October 16, 2024

Study of severe drug reactions finds skin cells activate their own assassins

Single-cell analysis reveals the inner workings of the life-threatening adverse drug reactions Stevens-Johnson syndrome and toxic epidermal necrolysis.
By Paul Govern
October 16, 2024

Study seeks to improve brain health in children with Type 1 diabetes

Children with Type 1 diabetes are at increased risk for neurocognitive complications. Vanderbilt University Medical Center has been selected as one of 11 clinical centers in the United States to evaluate children newly diagnosed with Type 1 diabetes for neurocognitive outcomes.
By Jessica Pasley
October 15, 2024

MEGAMicrobe event for children set for Saturday, Oct. 26

The seventh annual event invites students to conduct science experiments, join in hands-on activities, and win prizes and giveaways.
By Bill Snyder
October 7, 2024

New Video: Study shows cancer vaccine blocks tumor progression at early lesion stage

Senior author Mary Philip, MD, PhD, associate director of the Vanderbilt Institute for Infection, Immunology and Inflammation, talks about her Journal for ImmunoTherapy of Cancer study. The findings support further vaccine investigation to make long-term, progression-free survival a reality for more cancer patients.
By Tom Wilemon
October 3, 2024

VUMC hosts symposium for aspiring physician-scientists

The event brings physician-scientists, resident physicians, MD, MD/PhD and undergraduate students together to promote mentorship, provide information and showcase student research.
By Bill Snyder
October 2, 2024

Grant funds quest to expand immunotherapy efficacy for colorectal cancer  

The study seeks to understand the mechanisms of colorectal cancer and builds on recent Vanderbilt research.
By Tom Wilemon
September 30, 2024

VUMC researchers awarded $1.9 million for AI-driven cancer data extraction

The project seeks to reduce the time for clinical chart abstraction by 90% while maintaining human-level accuracy.
By Paul Govern
1 2 3 4 … 125